Cargando…

Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors

SIMPLE SUMMARY: Chimeric antigen receptor (CAR) T cells are genetically engineered T cells that recognize markers present on tumor cells and drive the degradation of the tumor itself. CAR T immunotherapy has obtained remarkable success in targeting a number of blood malignancies; however, its outcom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boccalatte, Francesco, Mina, Roberto, Aroldi, Andrea, Leone, Sarah, Suryadevara, Carter M., Placantonakis, Dimitris G., Bruno, Benedetto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600451/ https://www.ncbi.nlm.nih.gov/pubmed/36291891 http://dx.doi.org/10.3390/cancers14205108

Ejemplares similares

Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment
por: Andrea, Alain E., et al.
Publicado: (2022)

Hurdles to breakthrough in CAR T cell therapy of solid tumors
por: Marofi, Faroogh, et al.
Publicado: (2022)

Current status and hurdles for CAR-T cell immune therapy
por: Zhao, Ruocong, et al.
Publicado: (2019)

CAR-T cell therapy in myeloma: hopes and hurdles
por: Harousseau, Jean Luc
Publicado: (2023)

Pancreatic cancer: Hurdles in the engineering of CAR-based immunotherapies
por: Abate-Daga, Daniel, et al.
Publicado: (2014)

Approval of First CAR-Ts: Have we Solved all Hurdles for ATMPs?
por: Seimetz, Diane, et al.
Publicado: (2019)

Recent Advances in CAR-Based Solid Tumor Immunotherapy
por: Shin, Min Hwa, et al.
Publicado: (2023)

CAR-T with License to Kill Solid Tumors in Search of a Winning Strategy
por: Sacchetti, Benedetto, et al.
Publicado: (2019)

Hepatocellular carcinoma treatment: hurdles, advances and prospects
por: Kumari, Ratna, et al.
Publicado: (2018)

CAR-T cells: the long and winding road to solid tumors
por: D’Aloia, Maria Michela, et al.
Publicado: (2018)

Making CAR T Cells a Solid Option for Solid Tumors
por: Schmidts, Andrea, et al.
Publicado: (2018)

Current Advances and Hurdles in Chimeric Antigen Receptor Technology
por: McComb, Scott, et al.
Publicado: (2020)

Tumour Microenvironment and Immune Evasion in EGFR Addicted NSCLC: Hurdles and Possibilities
por: Santaniello, Antonio, et al.
Publicado: (2019)

Tumor Microenvironment Immunosuppression: A Roadblock to CAR T-Cell Advancement in Solid Tumors
por: Johnson, Abigail, et al.
Publicado: (2022)

Computational Enzyme Design: Advances, hurdles and possible ways forward
por: Linder, Mats
Publicado: (2012)

The Therapeutic Potential of the Anticancer Activity of Fucoidan: Current Advances and Hurdles
por: Jin, Jun-O., et al.
Publicado: (2021)

Do Different Hurdle Heights Alter Important Spatiotemporal Variables in Hurdle Clearance?
por: Ozaki, Yusuke, et al.
Publicado: (2022)

Advances in Nanotechnology Development to Overcome Current Roadblocks in CAR-T Therapy for Solid Tumors
por: Mi, Juan, et al.
Publicado: (2022)

CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances
por: Maalej, Karama Makni, et al.
Publicado: (2023)

Ethical Hurdles in the Prioritization of Oncology Care
por: de Groot, Folkert, et al.
Publicado: (2016)

Maternal and neonatal immunization in the Americas: The benefits, the hurdles, and the way forward()
por: Pasetti, Marcela F., et al.
Publicado: (2021)

Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities
por: Tien, Feng-Ming, et al.
Publicado: (2023)

Major hurdles of immune-checkpoint inhibitors in pancreatic ductal adenocarcinoma
por: Akhuba, Liia, et al.
Publicado: (2023)

CAR-T: a potential gene carrier targeting solid tumor immune microenvironment
por: Wang, Minjie, et al.
Publicado: (2021)

Public policy action and CCC implementation: benefits and hurdles
por: Steger, Carter, et al.
Publicado: (2010)

Editorial: CAR T-Cell Therapies in Hematologic Tumors
por: Coscia, Marta, et al.
Publicado: (2020)

Recent advances in lineage differentiation from stem cells: hurdles and opportunities?
por: Terryn, Joke, et al.
Publicado: (2018)

Facilitations and Hurdles of Genetic Testing in Neuromuscular Disorders
por: Barp, Andrea, et al.
Publicado: (2021)

Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment
por: Titov, Aleksei, et al.
Publicado: (2020)

Humans in space: the psychological hurdles
por: Kanas, Nick
Publicado: (2015)

New hurdles for translational research
por: Dowsett, Mitch
Publicado: (2000)

Hurdles of publication: to authors to overcome
por: Mohammadhassanzadeh, Hafez, et al.
Publicado: (2014)

Hurdles to Cardioprotection in the Critically Ill
por: See Hoe, Louise E, et al.
Publicado: (2019)

Hurdles in Basic Science Translation
por: Perry, Christina J., et al.
Publicado: (2017)

Roadblocks to success for RNA CARs in solid tumors
por: Singh, Nathan, et al.
Publicado: (2015)

CAR T cells in solid tumors: challenges and opportunities
por: Marofi, Faroogh, et al.
Publicado: (2021)

CAR-NK Cells in the Treatment of Solid Tumors
por: Wrona, Ewa, et al.
Publicado: (2021)

CAR T Cell Locomotion in Solid Tumor Microenvironment
por: Nguyen, Duy T., et al.
Publicado: (2022)

CAR-T Therapies in Solid Tumors: Opportunities and Challenges
por: Guzman, Grace, et al.
Publicado: (2023)

CAR T-Cell Therapy in Children with Solid Tumors
por: Kulczycka, Marika, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5516bhnph9vaa605u767g4bt0h